Recce breathes better on positive lung infection drug pilot test results
Recce Pharmaceuticals Ltd has revealed positive results from its pilot test on synthetic drug Recce 327, which aims to treat lung infections.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
MCH | Ann: Removal from Official List | 03/02/20 | 0 | 554 | |||
|
|||||||
MCH | Ann: Notice of resumption of adjourned 2018 AGM | 31/01/20 | 2 | 1.5K | |||
|
|||||||
MCH | Ann: Notice of resumption of adjourned 2017 AGM | 22/01/20 | 0 | 367 | |||
|
|||||||
MCH | Ann: Notice of Annual General Meeting/Proxy Form | 21/01/20 | 0 | 815 | |||
|
|||||||
MCH | Ann: Annual Report to shareholders | 26/12/19 | 1 | 818 | |||
|
|||||||
MCH | Ann: Delay in lodgement of 2019 annual report | 28/10/19 | 1 | 786 | |||
|
|||||||
MCH | Ann: 2018 Annual Report to shareholders | 23/09/19 | 0 | 510 | |||
|
|||||||
MCH | Ann: 2018 Half Year Accounts | 23/09/19 | 0 | 398 | |||
|
See All Discussions